Jupiter Wellness to Offer Clinical Research Services with Acquisition of Ascent Clinical Research: $3 Million Annual Revenue & EBITDA Contribution to Jupiter

2 years ago

IN A BID TO EXPAND JUPITER WELLNESS'S RESEARCH CAPABILITIES AND ENTER THE LUCRATIVE CRO BUSINESS, JUPITER WELLNESS ACQUIRED THE ASSETS…

Amarantus Signs Non-Binding Term Sheet to Divest Cutanogen Corporation in Exchange for the Extinguishment of Potential $21M+ in Liabilities

2 years ago

Board Member/Acting CEO Provides Shareholder UpdateSale of Engineered Skin Substitute (ESS) subsidiary, Cutanogen Corporation.Emphasis placed on advancing Elto Pharma, Inc.…

NeoGenomics Reports Revenue of $117 Million in the First Quarter

2 years ago

First-Quarter 2022 ResultsConsolidated revenue increased 1% to $117 million; excluding 2021 COVID-19 PCR testing revenue, consolidated revenue increased 3%Clinical Services…

Zomedica to Present at H.C. Wainwright Global Investment Conference

2 years ago

ANN ARBOR, MI / ACCESSWIRE / April 27, 2022 / Zomedica Corp. (NYSE American:ZOM), a veterinary health company offering point-of-care diagnostics…

AXIM Develops Quantitative Rapid Diagnostic Test for Lacritin; Now Boasts Four Dry Eye Disease Point-of-Care Biomarker Tests

2 years ago

SAN DIEGO, April 27, 2022 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare…

Truepill Names Doreen Bortel as Chief Growth Officer

2 years ago

SAN MATEO, Calif., April 27, 2022 (GLOBE NEWSWIRE) -- Truepill, the digital health platform connecting telehealth, diagnostics, and pharmacy infrastructure…

Michael Hammond Appointed to the Healthmap Solutions Board of Directors

2 years ago

Health System Industry Veteran Joins Healthmap Solutions Board as Need for Kidney Health Management Solutions SurgesTAMPA, Fla., April 27, 2022…

Alliance for Regenerative Medicine Announces CEO Transition

2 years ago

CEO to step down after leading ARM through period of tremendous growth; New Officer Roles AnnouncedWashington, DC, April 27, 2022…

Rakovina Therapeutics Inc. Announces 2021 Financial Results and Provides Corporate Update

2 years ago

VANCOUVER, British Columbia, April 27, 2022 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company”) a biopharmaceutical company committed…